Mechanical Massage Chair on Musculoskeletal Pain Improvement

Sponsor
Seoul National University Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT04351477
Collaborator
(none)
25
1
2
10.9
2.3

Study Details

Study Description

Brief Summary

The effect of mechanical massage chair on musculoskeletal pain improvement for endoscopists and endoscopy nurses

Condition or Disease Intervention/Treatment Phase
  • Device: Massage chair
N/A

Detailed Description

Randomized, open-label, cross-over study

  1. 1st phase Massage chair group (20 minutes/session, 3 sessions/week, 3 weeks), vs. control (no use of massage chair)

  2. Wash-out period (9 weeks)

  3. 2nd phase (cross-over) Massage chair group (20 minutes/session, 3 sessions/week, 3 weeks), vs. control (no use of massage chair)

  • Msculoskeletal pain questionnaires (VAS, NDI, SPADI)
  1. 1st phase: at baseline, 1.5 wk, 3 wk 2) 2nd phase: at baseline, 1.5 wk, 3 wk, 9wk after the end of treatment

Study Design

Study Type:
Interventional
Anticipated Enrollment :
25 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Randomized, open-label, cross-over studyRandomized, open-label, cross-over study
Masking:
None (Open Label)
Masking Description:
Randomization by allocation concealment Open label, cross-over design
Primary Purpose:
Other
Official Title:
The Effect of Mechanical Massage Chair on Musculoskeletal Pain Improvement for Endoscopists and Endoscopy Nurses
Anticipated Study Start Date :
Jun 1, 2020
Anticipated Primary Completion Date :
Apr 30, 2021
Anticipated Study Completion Date :
Apr 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Massage chair group

Use mechanical massage chair for 20 minutes/1 session, 3 sessions/week, for 3 weeks

Device: Massage chair
Mechanical massage chair
Other Names:
  • Bodyfriend
  • No Intervention: Control

    No use of mechanical massage chair for 3 weeks

    Outcome Measures

    Primary Outcome Measures

    1. Visual analogue scale [The change of VAS value at baseline, 1.5 week, 3 weeks during treatment, and 9 weeks after treatment]

      range: 0-10 (0: no pain; 10: worst possible pain)

    Secondary Outcome Measures

    1. Neck disability index (NDI) [The change at baseline, 1.5 week, 3 weeks during treatment, and 9 weeks after treatment]

      range: 0-50 score (0: no pain or no disability, 50: worst pain or disability)

    2. Shoulder pain and disability index (SPADI) [The change at baseline, 1.5 week, 3 weeks during treatment, and 9 weeks after treatment]

      range: 0-100% (0: no pain or no disability, 100: worst pain or disability)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Endoscopists or endoscopic nurses working at Seoul National University Hospital Gangnam Center
    Exclusion Criteria:
    • Spine disease, skin disease, acute inflammation, electrical heart device, thromboembolism, fracture, osteoporosis, varicose vein

    • Pregnancy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Healthcare System Gangnam Center, Seoul National University Hospital Seoul Korea, Republic of

    Sponsors and Collaborators

    • Seoul National University Hospital

    Investigators

    • Principal Investigator: Min-Sun Kwak, MD, PhD, Seoul National University Hospital Gangnam Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Su Jin Chung, Professor, Seoul National University Hospital
    ClinicalTrials.gov Identifier:
    NCT04351477
    Other Study ID Numbers:
    • 20200413
    First Posted:
    Apr 17, 2020
    Last Update Posted:
    Apr 22, 2020
    Last Verified:
    Apr 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Su Jin Chung, Professor, Seoul National University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 22, 2020